Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Axcella Health stock

Own Axcella Health stock in just a few minutes.

Posted

Fact checked

Axcella Health Inc is a biotechnology business based in the US. Axcella Health shares (AXLA) are listed on the NASDAQ and all prices are listed in US Dollars. Axcella Health employs 69 staff and has a market cap (total outstanding shares value) of USD$175.7 million.

How to buy shares in Axcella Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Axcella Health. Find the stock by name or ticker symbol: AXLA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Axcella Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Axcella Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Axcella Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Axcella Health share price

Use our graph to track the performance of AXLA stocks over time.

Axcella Health shares at a glance

Information last updated 2020-10-19.
52-week range USD$2.25 - USD$7.73
50-day moving average USD$4.7338
200-day moving average USD$4.923
Wall St. target price USD$15.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-6.036

Buy Axcella Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Axcella Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Axcella Health financials

Gross profit TTM USD$0
Return on assets TTM -30.36%
Return on equity TTM -67.7%
Profit margin 0%
Book value $2.565
Market capitalisation USD$175.7 million

TTM: trailing 12 months

Shorting Axcella Health shares

There are currently 378,354 Axcella Health shares held short by investors – that's known as Axcella Health's "short interest". This figure is 13.1% up from 334,468 last month.

There are a few different ways that this level of interest in shorting Axcella Health shares can be evaluated.

Axcella Health's "short interest ratio" (SIR)

Axcella Health's "short interest ratio" (SIR) is the quantity of Axcella Health shares currently shorted divided by the average quantity of Axcella Health shares traded daily (recently around 168157.33333333). Axcella Health's SIR currently stands at 2.25. In other words for every 100,000 Axcella Health shares traded daily on the market, roughly 2250 shares are currently held short.

However Axcella Health's short interest can also be evaluated against the total number of Axcella Health shares, or, against the total number of tradable Axcella Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Axcella Health's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Axcella Health shares in existence, roughly 10 shares are currently held short) or 0.0182% of the tradable shares (for every 100,000 tradable Axcella Health shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Axcella Health.

Find out more about how you can short Axcella Health stock.

Axcella Health share dividends

We're not expecting Axcella Health to pay a dividend over the next 12 months.

Axcella Health overview

Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site